Jason H. Gill

2.3k total citations
56 papers, 1.8k citations indexed

About

Jason H. Gill is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jason H. Gill has authored 56 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 22 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Jason H. Gill's work include Peptidase Inhibition and Analysis (8 papers), Protease and Inhibitor Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Jason H. Gill is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), Protease and Inhibitor Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Jason H. Gill collaborates with scholars based in United Kingdom, United States and Australia. Jason H. Gill's co-authors include Jill M. Seargent, Jonathan P. Laye, Paul M. Loadman, Steven D. Shnyder, Michael C. Bibby, Jennifer M. Atkinson, Ruth Roberts, Iduna Fichtner, Neil H. James and Eric B. Wheeldon and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Jason H. Gill

54 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason H. Gill United Kingdom 24 961 472 460 235 223 56 1.8k
Renata Jaskula‐Sztul United States 27 1.0k 1.1× 508 1.1× 233 0.5× 286 1.2× 205 0.9× 67 1.9k
Wei Xia China 20 742 0.8× 331 0.7× 212 0.5× 196 0.8× 227 1.0× 44 1.6k
Hongsheng Wang China 21 845 0.9× 575 1.2× 337 0.7× 176 0.7× 143 0.6× 49 1.6k
Feifei Li China 27 1.4k 1.5× 241 0.5× 453 1.0× 195 0.8× 104 0.5× 120 2.2k
Jürgen Thomale Germany 29 1.7k 1.8× 765 1.6× 558 1.2× 331 1.4× 231 1.0× 76 2.8k
Jan Hraběta Czechia 23 1.6k 1.7× 606 1.3× 273 0.6× 138 0.6× 152 0.7× 53 2.5k
Peng Sun China 28 1.3k 1.4× 350 0.7× 683 1.5× 392 1.7× 266 1.2× 114 2.5k
Jie Gao China 24 910 0.9× 251 0.5× 296 0.6× 235 1.0× 164 0.7× 90 1.7k
Valentina De Falco Italy 25 1.3k 1.3× 892 1.9× 274 0.6× 218 0.9× 183 0.8× 40 2.6k

Countries citing papers authored by Jason H. Gill

Since Specialization
Citations

This map shows the geographic impact of Jason H. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason H. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason H. Gill more than expected).

Fields of papers citing papers by Jason H. Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason H. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason H. Gill. The network helps show where Jason H. Gill may publish in the future.

Co-authorship network of co-authors of Jason H. Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Jason H. Gill. A scholar is included among the top collaborators of Jason H. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason H. Gill. Jason H. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Yucheng, et al.. (2025). Structural isomerisation affects the antitubercular activity of adamantyl-isoxyl adducts. Journal of Enzyme Inhibition and Medicinal Chemistry. 40(1). 2502600–2502600.
2.
Redgrave, Rachael E., Emily Dookun, Simon Tual‐Chalot, et al.. (2023). Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction. PubMed. 9(1). 15–15. 37 indexed citations
3.
Abdelghany, Tarek M., et al.. (2022). Potential for cardiac toxicity with methylimidazolium ionic liquids. Ecotoxicology and Environmental Safety. 249. 114439–114439. 8 indexed citations
4.
Gill, Jason H., et al.. (2022). Baseline blood pressure and development of cardiotoxicity in patients treated with anthracyclines: A systematic review. International Journal of Cardiology Cardiovascular Risk and Prevention. 15. 200153–200153. 7 indexed citations
5.
Brown, Alistair K., et al.. (2020). Identification of Substituted Amino Acid Hydrazides as Novel Anti-Tubercular Agents, Using a Scaffold Hopping Approach. Molecules. 25(10). 2387–2387. 5 indexed citations
6.
Oldershaw, Rachel A., W. Andrew Owens, Gendie E. Lash, et al.. (2019). Human Cardiac-Mesenchymal Stem Cell-Like Cells, a Novel Cell Population with Therapeutic Potential. Stem Cells and Development. 28(9). 593–607. 16 indexed citations
7.
Brown, Alistair K., et al.. (2019). Identification of Novel Benzoxa-[2,1,3]-diazole Substituted Amino Acid Hydrazides as Potential Anti-Tubercular Agents. Molecules. 24(4). 811–811. 7 indexed citations
8.
Gill, Jason H., et al.. (2019). Chronic cardiovascular toxicity in the older oncology patient population. Journal of Geriatric Oncology. 10(5). 685–689. 7 indexed citations
9.
Todd, Adam, Paul W. Groundwater, & Jason H. Gill. (2017). Antimicrotubule Agents. PubMed. 20(1). 211–232.
10.
Jamie, Kimberly, Hannah Bows, & Jason H. Gill. (2016). Integration of pharmacogenetic principles as a core thread in the undergraduate pharmacy curriculum.. Durham Research Online (Durham University). 1 indexed citations
11.
Gill, Jason H., Paul M. Loadman, Steven D. Shnyder, et al.. (2014). Tumor-Targeted Prodrug ICT2588 Demonstrates Therapeutic Activity against Solid Tumors and Reduced Potential for Cardiovascular Toxicity. Molecular Pharmaceutics. 11(4). 1294–1300. 25 indexed citations
12.
O’Farrell, Alice C., et al.. (2013). Non‐invasive molecular imaging for preclinical cancer therapeutic development. British Journal of Pharmacology. 169(4). 719–735. 69 indexed citations
13.
Sutherland, Mark, Jason H. Gill, Paul M. Loadman, et al.. (2012). Antitumor Activity of a Duocarmycin Analogue Rationalized to Be Metabolically Activated by Cytochrome P450 1A1 in Human Transitional Cell Carcinoma of the Bladder. Molecular Cancer Therapeutics. 12(1). 27–37. 36 indexed citations
14.
Atkinson, Jennifer M., Robert A. Falconer, Dylan R. Edwards, et al.. (2010). Development of a Novel Tumor-Targeted Vascular Disrupting Agent Activated by Membrane-Type Matrix Metalloproteinases. Cancer Research. 70(17). 6902–6912. 48 indexed citations
15.
Atkinson, Jennifer M., Catherine S. Siller, & Jason H. Gill. (2008). Tumour endoproteases: the cutting edge of cancer drug delivery?. British Journal of Pharmacology. 153(7). 1344–1352. 42 indexed citations
16.
Behrens, Diana, Jason H. Gill, & Iduna Fichtner. (2007). Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells. Molecular and Cellular Endocrinology. 274(1-2). 19–29. 34 indexed citations
17.
Atkinson, Jennifer M., C. Pennington, Alan J. Mearns, et al.. (2007). Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: Correlation of MMP-14 mRNA expression and proteolytic activity. European Journal of Cancer. 43(11). 1764–1771. 40 indexed citations
18.
Gibson, Paul, Jason H. Gill, Jill M. Seargent, et al.. (2003). Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development.. Bradford Scholars (University of Bradford). 2(6). 527–34. 80 indexed citations
19.
Nishiyama, Hiroyuki, Jason H. Gill, Eva Pitt, Wendy Kennedy, & Margaret A. Knowles. (2001). Negative regulation of G1/S transition by the candidate bladder tumour suppressor gene DBCCR1. Oncogene. 20(23). 2956–2964. 47 indexed citations
20.
Roberts, Ruth, Anthony R. Soames, Jason H. Gill, Neil H. James, & Eric B. Wheeldon. (1995). Non-genotoxic hepatocarcinogenesis stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis. 16(8). 1693–1698. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renata Jaskula‐Sztul Breakdown of academic impact, for papers by Wei Xia Breakdown of academic impact, for papers by Hongsheng Wang Breakdown of academic impact, for papers by Feifei Li Breakdown of academic impact, for papers by Jürgen Thomale Breakdown of academic impact, for papers by Jan Hraběta Breakdown of academic impact, for papers by Peng Sun Breakdown of academic impact, for papers by Jie Gao Breakdown of academic impact, for papers by Valentina De Falco
Rankless by CCL
2026